TRCT
LEXX icon

Tower Research Capital (TRC)’s Lexaria Bioscience LEXX Stock Holding History

Tower Research Capital (TRC)’s Portfolio LEXX Stock Details LEXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$85 Buy
+10
New +$108 ﹤0.01% 5140
2026
Q1 		– Sell
-2
Closed -$22 – 5078
2025
Q4 		$20 Sell
2
-239
-99% -$3.39K ﹤0.01% 5100
2025
Q3 		$3.45K Buy
241
+110
+84% +$1.6K ﹤0.01% 4501
2025
Q2 		$1.71K Buy
131
+44
+51% +$758 ﹤0.01% 4758
2025
Q1 		$2.22K Sell
87
-52
-37% -$1.32K ﹤0.01% 4576
2024
Q4 		$4.37K Buy
139
+49
+54% +$1.81K ﹤0.01% 4473
2024
Q3 		$4.1K Sell
90
-135
-60% -$6.44K ﹤0.01% 4673
2024
Q2 		$9.37K Buy
225
+45
+25% +$2.02K ﹤0.01% 4260
2024
Q1 		$9.81K Sell
180
-207
-53% -$7.91K ﹤0.01% 3787
2023
Q4 		$7.26K Sell
387
-168
-30% -$3.25K ﹤0.01% 4638
2023
Q3 		$8.33K Sell
555
-175
-24% -$2.4K ﹤0.01% 4362
2023
Q2 		$7.99K Buy
730
+457
+167% +$8.88K ﹤0.01% 4490
2023
Q1 		$11K Sell
273
-62
-19% -$2.65K ﹤0.01% 4232
2022
Q4 		$12K Buy
335
+93
+38% +$3.34K ﹤0.01% 3723
2022
Q3 		$9K Buy
+242
New +$10.3K ﹤0.01% 4665
2022
Q2 		– Sell
-204
Closed -$10K – 6330
2022
Q1 		$10K Buy
204
+124
+155% +$7.02K ﹤0.01% 4318
2021
Q4 		$5K Buy
+80
New +$6.83K ﹤0.01% 5163
2021
Q3 		– Sell
-17
Closed -$2K – 5979
2021
Q2 		$2K Buy
+17
New +$1.52K ﹤0.01% 5051

Other funds holding LEXX

ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Tower Research Capital (TRC)'s LEXX Position: Q2 2026 in Review

Tower Research Capital (TRC) opened a new position in Lexaria Bioscience (LEXX) in Q2 2026: 10 shares worth $85. The stake represents ﹤0.01% of the portfolio and ranks #5140 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in LEXX as recently as Q4 2025.

Tower Research Capital (TRC) first reported a position in LEXX in Q2 2021 and has held it in 18 quarters since. The position peaked at $12K in Q4 2022. 29 funds tracked by Wall St. Rank hold LEXX as of Q2 2026.

  • Tower Research Capital (TRC) held 10 shares of Lexaria Bioscience worth $85 as of Q2 2026.
  • Lexaria Bioscience was a new Tower Research Capital (TRC) position in Q2 2026.
  • Lexaria Bioscience made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #5140 holding.
  • Tower Research Capital (TRC) first reported a position in Lexaria Bioscience in Q2 2021 and has held it in 18 quarters since.
  • Tower Research Capital (TRC)'s Lexaria Bioscience position peaked at $12K in Q4 2022.
  • 29 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.